Topically Active Carbonic Anhydrase Inhibitors for Glaucoma
- 1 January 1991
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 109 (1) , 38-40
- https://doi.org/10.1001/archopht.1991.01080010040028
Abstract
Research from JAMA Ophthalmology — Topically Active Carbonic Anhydrase Inhibitors for GlaucomaThis publication has 10 references indexed in Scilit:
- A single dose of the topical carbonic anhydrase inhibitor MK-927 decreases IOP in patients.British Journal of Ophthalmology, 1990
- The Ocular Hypotensive Effect of the Topical Carbonic Anhydrase Inhibitor L-671,152 in Glaucomatous MonkeysArchives of Ophthalmology (1950), 1990
- Chemical and pharmacological properties of MK-927, a sulfonamide carbonic anhydrase inhibitor that lowers intraocular pressure by the topical routeExperimental Eye Research, 1990
- A comparison of L-671,152 and MK-927, two topically effective ocular hypotensive carbonic anhydrase inhibitors, in experimental animalsCurrent Eye Research, 1990
- The effect of MK-927, a topical carbonic anhydrase inhibitor, on IOP in glaucomatous monkeysCurrent Eye Research, 1990
- Local Tolerance and Activity of MK-927, a Novel Topical Carbonic Anhydrase InhibitorArchives of Ophthalmology (1950), 1988
- Carbonic anhydrase: General perspective and advances in glaucoma researchDrug Development Research, 1987
- Topical Acetazolamide and Methazolamide Delivered by Contact LensesArchives of Ophthalmology (1950), 1985
- The transcorneal permeability of sulfonamide carbonic anhydrase inhibitors and their effect on aqueous humor secretionExperimental Eye Research, 1983
- Effects of Locally Administered Diamox*American Journal of Ophthalmology, 1955